Financhill
Back

Cyclacel Pharmaceuticals Stock Predictions

Cyclacel Pharmaceuticals Stock Forecast

  • Is Cyclacel Pharmaceuticals Stock Undervalued?
    The current Cyclacel Pharmaceuticals [CYCC] share price is $0.36. The Score for CYCC is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • CYCC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Cyclacel Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Cyclacel Pharmaceuticals Stock Rating

Data Unavailable

Cyclacel Pharmaceuticals Stock Price History

Is CYCC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYCC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Malaysia
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cyclacel.com

52-Week Data

52-Week High:
39.84
52-Week Low:
0.25

Prediction Charts

Market Cap:
8.5M
Price in USD:
0.36
Volume:
4.2M
Beta:
1.46

Technical Analysis

SMA50:
2.84
SMA100:
4.04
SMA200:
7.42
52-Wk Change:
-98.68%

Stock Predictions

  • Is Cyclacel Pharmaceuticals stock public?
    Yes, Cyclacel Pharmaceuticals is a publicly traded company.
  • What is the Cyclacel Pharmaceuticals stock quote today?
    The Cyclacel Pharmaceuticals stock price is 0.36 USD today.
  • How to buy Cyclacel Pharmaceuticals stock online?
    You can buy Cyclacel Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-23 1.45 1.45 1.56 1.36
May-27 1.44 1.62 1.68 1.44
May-28 1.63 1.75 1.94 1.58
May-29 1.76 1.60 1.76 1.56
May-30 1.56 1.63 1.82 1.56
Jun-2 1.61 1.64 1.74 1.60
Jun-3 1.62 1.67 1.72 1.59
Jun-4 1.62 1.45 1.73 1.35
Jun-5 1.46 0.61 1.55 0.58
Jun-6 0.61 0.37 0.66 0.35
Jun-9 0.40 0.34 0.41 0.29
Jun-10 0.34 0.28 0.34 0.25
Jun-11 0.29 0.32 0.38 0.27
Jun-12 0.32 0.36 0.36 0.31

Cyclacel Pharmaceuticals Earnings

Data Unavailable

Cyclacel Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $8.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.06 per share.

* Cyclacel Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.